Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages.
J Infect Dis
Oxford University Press (OUP)
MetadataShow full item record
Nyberg, T., Harman, K., Zaidi, A., Seaman, S. R., Andrews, N., Nash, S. G., Charlett, A., et al. (2022). Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages.. J Infect Dis https://doi.org/10.1093/infdis/jiac063
Funder: NIHR Health Protection Unit in Behavioural Science and Evaluation
To investigate if the AY.4.2 sublineage of the SARS-CoV-2 delta variant is associated with hospitalization and mortality risks that differ from non-AY.4.2 delta risks, we performed a retrospective cohort study of sequencing-confirmed COVID-19 cases in England based on linkage of routine health care datasets. Using stratified Cox regression, we estimated adjusted hazard ratios (aHR) of hospital admission (aHR = 0.85; 95% confidence interval [CI], .77-.94), hospital admission or emergency care attendance (aHR = 0.87; 95% CI, .81-.94), and COVID-19 mortality (aHR = 0.85; 95% CI, .71-1.03). The results indicate that the risks of hospitalization and mortality are similar or lower for AY.4.2 compared to cases with other delta sublineages.
Mortality, Hospitalisation, Covid-19, Sars-cov-2, Ay.4.2, Vui-21oct-01
UKRI Medical Research Council (MC_UU_00002/11; MC_UU_00002/10); MRC UKRI/DHSC NIHR COVID-19 rapid response call (MC_PC_19074); NIHR Health Protection Unit in Behavioural Science and Evaluation; NIHR Cambridge Biomedical Research Centre (BRC-1215-20014)
MRC (MC_PC 19074)
National Institute for Health Research (NIHR) (via University of Bristol) (200877 2020 - 245)
National Institute for Health Research (IS-BRC-1215-20014)
External DOI: https://doi.org/10.1093/infdis/jiac063
This record's URL: https://www.repository.cam.ac.uk/handle/1810/335385
Attribution 4.0 International
Licence URL: https://creativecommons.org/licenses/by/4.0/